Sign in

CIK 0001501989

  • Accelerated filer

CytomX Therapeutics, Inc.

Sign in to watch
Ticker
CTMX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
273521219
Phone
+1 650-515-3185
Business address
151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Open-market sale Director sold 25,082 shares at $10.60 ($265,869)
  2. 4 Open-market sale Director sold 25,082 shares at $10.60 ($265,869)
  3. 4 Open-market sale Director sold 51,343 shares at an average $10.34 ($530,811)
  4. 4 Open-market sale Director sold 51,343 shares at an average $10.34 ($530,811)
  5. 4 Open-market sale Director sold 13,253 shares at an average $10.09 ($133,735)
  6. 4 Open-market sale Director sold 13,253 shares at an average $10.09 ($133,735)
  7. 4 Open-market sale Director sold 8,687 shares at an average $10.10 ($87,777)
  8. 4 Open-market sale Director sold 8,687 shares at an average $10.10 ($87,777)
  9. 4 Exercise or conversion Chief Financial Officer acquired 2,000 shares (option exercise)
  10. 4 Other disposition Director disposed of 300,000 shares (other)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Exercise or conversion Chief Scientific Officer and acquired 8,917 shares (option exercise)
  17. 4 Conversion 10% owner acquired 8,670,351 shares (conversion)
  18. 4 Conversion Director acquired 4,884,755 shares (conversion)
  19. 4 Open-market buy Senior VP and General Counsel bought 3,000 shares at $12.00 ($36,000)
  20. 4 Open-market buy CSO, Head Res.&Non-Clin. Dev. bought 5,000 shares at $12.00 ($60,000)

Page 19 of 20 · 400 filings